Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors.
Journal: Frontiers in oncology
Year: July 25, 2019
Oncologist
5
No OPD information available
Gliosarcoma
Nirmitha I. Herath is a medical professional who specializes in treating a type of brain cancer called Gliosarcoma. Gliosarcoma is a rare and aggressive form of brain tumor.
Nirmitha I. Herath provides care and treatment to patients with Gliosarcoma. They have special skills and knowledge in managing this specific type of cancer. Their goal is to help patients fight the disease and improve their quality of life.
Nirmitha I. Herath communicates with patients in a caring and compassionate manner. Patients trust them because they listen to their concerns, explain treatment options clearly, and involve them in decision-making about their care.
To stay updated with the latest medical knowledge and research, Nirmitha I. Herath regularly attends conferences, reads scientific journals, and collaborates with other healthcare professionals. This helps them provide the best and most current treatments to their patients.
Nirmitha I. Herath works closely with colleagues and other medical professionals to ensure that patients receive comprehensive care. They value teamwork and collaboration to achieve the best outcomes for their patients.
Through their work, Nirmitha I. Herath has positively impacted the lives and health of many patients with Gliosarcoma. Their dedication to research and innovative treatments has led to better outcomes and improved survival rates for patients with this challenging disease.
One of Nirmitha I. Herath's notable publications is a study titled "Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors," published in Frontiers in Oncology on July 25, 2019. This research contributes to the understanding of new treatment options for cancer patients.
In summary, Nirmitha I. Herath is a skilled and compassionate medical professional who specializes in treating Gliosarcoma. Their dedication to patient care, commitment to staying updated with the latest research, and collaborative approach with colleagues have made a significant impact on the lives of patients battling this challenging disease.
Journal: Frontiers in oncology
Year: July 25, 2019
Dr. Herath is a compassionate and knowledgeable oncologist who truly cares about his patients. He explained everything in a way that was easy for me to understand. Highly recommend!
I felt so comfortable and well taken care of by Dr. Herath during my cancer treatment. He is not only a skilled oncologist but also a kind and supportive doctor. Thank you for everything!
Dr. Herath is an exceptional oncologist who goes above and beyond for his patients. His expertise and genuine concern make all the difference in the world. I am grateful for his care.
I cannot thank Dr. Herath enough for his dedication and expertise in treating my cancer. He is a top-notch oncologist who truly puts his patients first. Highly recommend him to anyone in need.
Dr. Herath is an outstanding oncologist who provides exceptional care with a warm and friendly approach. He made me feel at ease throughout my treatment journey. Highly satisfied with his services.
Dr. Herath is a brilliant oncologist who is not only highly skilled but also incredibly compassionate. He took the time to listen to my concerns and provided personalized care. I am so grateful for his expertise.